Turtlemint Fintech Solutions Limited Q4 FY26 earnings call summary

Earnings call of 17 Jul 2026, summarised by AI from the filing.

Health business grew more than 60% in FY26, driving overall growth.

Key takeaways

1. Health insurance Health business grew more than 60% in FY26, driving overall growth.
2. Commission regulation Uncertainty on commission regulation; management cannot predict discussion paper impact.

Original filing on BSE

Turtlemint Fintech Solutions Limited Q1 FY27 results

As filed: Revenue ₹294 cr, EBITDA −₹33.0 cr, PAT −₹37.8 cr, EBITDA margin -11.2%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹294 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

• Q4 FY26: Revenue ₹357 cr, EBITDA −₹3.9 cr, PAT ₹3.1 cr, EBITDA margin -1.1%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹357 cr). Scored once a year-earlier consolidated quarter exists.

Past price moves after results do not indicate future moves. Not a recommendation.

Turtlemint Fintech Solutions Limited earnings call, investor presentation and press release summaries

• Q1 FY27: Earnings call (14 Aug 2026), Results deck (14 Aug 2026), Results press release (14 Aug 2026)
• Q4 FY26: Earnings call (17 Jul 2026), Results deck (17 Jul 2026), Results press release (17 Jul 2026)